Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib in Relapsed/Refractory MCL Post-Ibrutinib
NCT02455297Phase 2Terminated
- Sponsor
- Bayer
- Start
- Aug 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in mantle cell lymphoma (MCL), sponsored by Bayer. Started Aug 2015; status: terminated.
02
Drugs
copanlisib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02455297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455297.